Equity · Healthcare
ALVO
Alvotech · NasdaqGM
The line runs $3.40 on 21 May through $3.95 on 18 August, on a scale from $2.5 to $4.5. Days the market did not trade hold the previous close, flat.
The chart above plots the price of ALVO over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $3.40 on 21 May 2026 through $3.95 on 18 August 2026.
Finazon · prior-day close · as of Aug 19, 2026
Filings 3 sets
ALVO reported financials
ALVO reported revenue from contracts with customers of $586.3M for the fiscal year ended 31 Dec 2025. Net income over the same period was $27.9M.
Source: SEC EDGAR XBRL company facts · latest period ended 31 Dec 2025
ALVO institutional holders
5 of the 45 institutional funds we track reported a ALVO position for the quarter ended 30 Jun 2026 — a combined $22.9M; the latest of those filings landed 14 Aug 2026.
Source: SEC EDGAR 13F filings
ALVO fails-to-deliver
On 31 Jul 2026, 14,821 shares of ALVO failed to deliver (about $53K) — the latest of 2 consecutive trading days with recorded fails.
Source: SEC fails-to-deliver (CNS) data